Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Calcitriol; Celecoxib
- Indications Head and neck cancer
- Focus Pharmacodynamics
Most Recent Events
- 07 Mar 2017 Biomarkers information updated
- 09 Jan 2010 Planned end date changed from 1 Oct 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 09 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.